Return to Home Mortality > Table > Data Table

Data Table for Rate/Trend Comparison by State/County

Death Rate/Trend Comparison by State/County, 2011-2015

Puerto Rico 8 versus United States

All Races, Both Sexes

Cancer Site and Sex
 sort alphabetically by cancer site ascending
Priority Index1
1=highest
9=lowest

 sort by priority index descending
Recent Trend2
County Death
Rate
Compared
to
US Rate
Average Annual Count
 sort by count descending
Age-Adjusted Death Rate

deaths per 100,000
(95% Confidence Interval)
 sort by rate descending
Rate
Ratio3
County
to
US
 sort by rate descending
Recent 5-Year Trend2 in Death Rates
(95% Confidence Interval)
 sort by trend descending
Oral Cavity & Pharynx (Male) 4 stable stable trend higher 99 4.9 (4.5, 5.4) 1.3 3.7 (-10.6, 20.3)
Prostate (Male) 4 stable stable trend higher 492 26.7 (25.7, 27.8) 1.4 -3.1 (-6.9, 0.8)
Stomach (Female) 4 stable stable trend higher 90 3.5 (3.2, 3.9) 1.5 -1.5 (-9.5, 7.3)
Stomach (Male) 4 stable stable trend higher 130 6.8 (6.3, 7.3) 1.6 -2.1 (-6.4, 2.4)
Breast (Female) 6 stable stable trend similar 433 17.9 (17.2, 18.7) 0.9 -0.7 (-4.2, 3.0)
Cervix (Female) 6 stable stable trend similar 52 2.5 (2.2, 2.8) 1.1 -3.2 (-13.8, 8.8)
Childhood (Ages <15, All Sites) (Female) 6 stable stable trend similar 5 1.6 (1.0, 2.4) 0.8 3.0 (-23.5, 38.8)
Childhood (Ages <15, All Sites) (Male) 6 stable stable trend similar 6 1.7 (1.1, 2.4) 0.7 -6.6 (-23.0, 13.2)
Childhood (Ages <20, All Sites) (Female) 6 stable stable trend similar 8 1.9 (1.4, 2.5) 0.9 -6.9 (-31.6, 26.6)
Childhood (Ages <20, All Sites) (Male) 6 stable stable trend similar 10 2.2 (1.6, 2.8) 0.8 -5.7 (-20.0, 11.0)
Colon & Rectum (Female) 6 stable stable trend similar 311 12.2 (11.6, 12.9) 1.0 -2.3 (-7.2, 2.8)
Colon & Rectum (Male) 6 stable stable trend similar 383 19.7 (18.8, 20.6) 1.1 -1.8 (-9.3, 6.4)
Liver & Bile Duct (Female) 6 stable stable trend similar 111 4.3 (4.0, 4.7) 1.1 1.4 (-3.0, 5.9)
Liver & Bile Duct (Male) 6 stable stable trend similar 209 10.4 (9.7, 11.0) 1.1 -0.2 (-8.2, 8.4)
Uterus (Corpus & Uterus, NOS) (Female) 6 stable stable trend similar 106 4.4 (4.0, 4.8) 1.0 5.9 (-7.2, 20.9)
Bladder (Male) 7 stable stable trend lower 85 4.5 (4.1, 4.9) 0.6 -6.9 (-15.3, 2.3)
Brain & ONS (Female) 7 stable stable trend lower 51 2.2 (1.9, 2.5) 0.6 1.0 (-22.4, 31.4)
Brain & ONS (Male) 7 stable stable trend lower 56 3.0 (2.6, 3.3) 0.6 0.1 (-12.3, 14.1)
Esophagus (Female) 7 stable stable trend lower 21 0.8 (0.7, 1.0) 0.6 1.0 (-11.7, 15.6)
Esophagus (Male) 7 stable stable trend lower 87 4.4 (4.0, 4.8) 0.6 0.9 (-12.8, 16.9)
Kidney & Renal Pelvis (Female) 7 stable stable trend lower 29 1.1 (1.0, 1.3) 0.5 7.8 (-15.0, 36.7)
Kidney & Renal Pelvis (Male) 7 stable stable trend lower 52 2.6 (2.3, 3.0) 0.5 12.2 (-7.7, 36.4)
Leukemia (Female) 7 stable stable trend lower 76 3.2 (2.8, 3.5) 0.6 0.5 (-6.8, 8.4)
Leukemia (Male) 7 stable stable trend lower 100 5.4 (4.9, 5.9) 0.6 -2.4 (-6.7, 2.1)
Lung & Bronchus (Female) 7 stable stable trend lower 227 8.9 (8.4, 9.5) 0.3 -2.5 (-11.3, 7.1)
Lung & Bronchus (Male) 7 stable stable trend lower 390 19.8 (18.9, 20.7) 0.4 -2.6 (-6.8, 1.8)
Melanoma of the Skin (Female) 7 stable stable trend lower 6 0.2 (0.2, 0.4) 0.2 19.1 (-29.5, 101.3)
Melanoma of the Skin (Male) 7 stable stable trend lower 12 0.6 (0.5, 0.8) 0.2 -1.0 (-36.1, 53.4)
Non-Hodgkin Lymphoma (Female) 7 stable stable trend lower 63 2.6 (2.3, 2.9) 0.6 -4.4 (-11.9, 3.7)
Non-Hodgkin Lymphoma (Male) 7 stable stable trend lower 90 4.7 (4.2, 5.1) 0.6 3.1 (-3.6, 10.4)
Oral Cavity & Pharynx (Female) 7 stable stable trend lower 27 1.0 (0.9, 1.2) 0.8 -9.3 (-26.0, 11.2)
Ovary (Female) 7 stable stable trend lower 102 4.2 (3.8, 4.6) 0.6 0.4 (-7.7, 9.2)
Pancreas (Female) 7 stable stable trend lower 145 5.8 (5.3, 6.2) 0.6 -2.1 (-11.4, 8.3)
Pancreas (Male) 7 stable stable trend lower 157 7.9 (7.3, 8.5) 0.6 2.3 (-1.4, 6.2)
Thyroid (Female) 7 stable stable trend lower 8 0.3 (0.2, 0.4) 0.6 9.5 (-16.6, 43.6)
Thyroid (Male) 7 stable stable trend lower 7 0.4 (0.3, 0.5) 0.7 0.7 (-12.1, 15.3)
Bladder (Female) 9 falling falling trend lower 37 1.4 (1.2, 1.7) 0.7 -8.1 (-13.0, -2.9)
Notes:
Created by statecancerprofiles.cancer.gov on 03/23/2019 5:05 am.

Trend2
     Rising     when 95% confidence interval of average annual percent change is above 0.
     Stable     when 95% confidence interval of average annual percent change includes 0.
     Falling     when 95% confidence interval of average annual percent change is below 0.
Rate Comparison
     Above     when 95% confident the rate is above and Rate Ratio3 > 1.10
     Similar     when unable to conclude above or below with confidence.
     Below     when 95% confident the rate is below and Rate Ratio3 < 0.90

1 Priority indices were created by ordering from rates that are rising and above the comparison rate to rates that are falling and below the comparison rate.
2 Recent trend in death rates is usually an Average Annual Percent Change (AAPC) based on the APCs calculated by Joinpoint Version 4.6.0.0. Due to data availability issues, the time period and/or calculation method used in the calculation of the trends may differ for selected geographic areas.
3 Rate ratio is the county rate divided by the US rate. Previous versions of this table used one-year rates for states and five-year rates for counties. As of June 2018, only five-year rates are used.
Source: Death data provided by the National Vital Statistics System public use data file. Death rates calculated by the National Cancer Institute using SEER*Stat. Death rates are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). The Healthy People 2020 goals are based on rates adjusted using different methods but the differences should be minimal. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2015 US Population Data File is used with mortality data.
Note: When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate. Suppression is used to avoid misinterpretation when rates are unstable.

State Cancer Registries may provide more current or more local data. Data presented on the State Cancer Profiles Web Site may differ from statistics reported by the State Cancer Registries (for more information).
8 Due to data availability issues, the time period used in the calculation of the joinpoint regression model may differ for selected geographic areas.



Interpret Rankings provides insight into interpreting cancer statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.

Return to Top